The bill would limit what many people pay for covered inhalers, nebulizers, and related equipment used to treat asthma or chronic obstructive pulmonary disease (COPD). Starting in 2026, private health plans and Medicare could not apply a deductible to these products or charge more than $15 for a 30-day supply. The bill also would create a payment program for qualifying products provided to uninsured people. The program would depend on available appropriations, and participating providers would agree not to charge an uninsured person more than $15 for a month’s supply when the program pays for it.
If you have private insurance or Medicare, your cost for a covered product would be limited to $15 per 30-day supply, without a deductible. The products include inhaled medicines and equipment such as spacers and nebulizers. If you are uninsured, a participating provider could provide a product through the new program; the $15 limit would apply when a program payment is made. The bill has been referred to House committees and has not been enacted.
The bill does not provide an estimate of total program costs or the amount of federal payments. Payments for uninsured people would be subject to available appropriations. For individuals, the bill sets a maximum cost of $15 per 30-day supply in the circumstances described above.
No publicly available information.
No publicly available information.